Andre Turenne, President & CEO at Voyager Therapeutics, Inc. (VYGR), sold 21,410 shares at $13.36 ($286K) on 2020-01-21, disclosed to the SEC on 2020-01-29.
Open-market sale of $286k VYGR by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.36 | 10,705 | $143K | 50.0% |
| 2 | $13.36 | 10,705 | $143K | 50.0% |
| Total | $13.36 avg | 21,410 | $286K | 100% |
| Filing → |